✦ LIBER ✦

PUK18 Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Non-Diabetic Advanced Renal Disease – A Dutch Perspective

✍ Scribed by C.C. Adarkwah; A. Gandjour; M. Akkerman; S.M. Evers

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Cost-Effectiveness Analysis of Angiote

✍ Panagiotis C. Stafylas; Pantelis A. Sarafidis; Dimitrios M. Grekas; Anastasios N 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 230 KB

Combination treatment of angiotensin-II

✍ N. Nakao; A. Yoshimura; H. Morita; M. Takada; T. Kayano; T. Ideura 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Retraction—Combination treatment of angi

✍ The Editors of The Lancet 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 40 KB

RETRACTED: Combination treatment of angi

✍ Naoyuki Nakao; Ashio Yoshimura; Hiroyuki Morita; Masyuki Takada; Tsuguo Kayano; 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 305 KB

PDB46 Cost-Effectiveness of Angiotensin

✍ Adarkwah, C.C.; Evers, S.; Akkerman, M.; Gandjour, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Comparison of the renal effects of angio

✍ T. Baba; S. Murabayashi; K. Takebe 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 632 KB